Efficacy and Safety of Ipragliflozin in Japanese Patients With Type 2 Diabetes: Interim Outcome of the ASSIGN-K Study (Q36429733)

From Wikidata
Jump to navigation Jump to search
scientific article
edit
Language Label Description Also known as
English
Efficacy and Safety of Ipragliflozin in Japanese Patients With Type 2 Diabetes: Interim Outcome of the ASSIGN-K Study
scientific article

    Statements

    Efficacy and Safety of Ipragliflozin in Japanese Patients With Type 2 Diabetes: Interim Outcome of the ASSIGN-K Study (English)
    Takashi Iizuka
    Kotaro Iemitsu
    Masahiro Takihata
    Masahiko Takai
    Shigeru Nakajima
    Nobuaki Minami
    Shinichi Umezawa
    Akira Kanamori
    Hiroshi Takeda
    Takehiro Kawata
    Shogo Ito
    Taisuke Kikuchi
    Hikaru Amemiya
    Mizuki Kaneshiro
    Atsuko Mokubo
    Tetsuo Takuma
    Hideo Machimura
    Keiji Tanaka
    Taro Asakura
    Akira Kubota
    Sachio Aoyagi
    Kazuhiko Hoshino
    Masashi Ishikawa
    Yoko Matsuzawa
    Mitsuo Obana
    Nobuo Sasai
    Hideaki Kaneshige
    Fuyuki Minagawa
    Tatsuya Saito
    Kazuaki Shinoda
    Masaaki Miyakawa
    Yasushi Tanaka
    Yasuo Terauchi
    Ikuro Matsuba
    28 December 2015
    116-125

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit